Star Therapeutics
BiotechnologyWebsite
Star Therapeutics valuation and funding history | Last updated: September 22, 2025 | 3 funding rounds
Current Valuation
N/A
As of September 22, 2025
Total Funding Raised
$315.0M
Across 3 rounds
Last Round
Later Stage VC
$125.0M
Last Funding
Sep 2025
Funding date
Capital Efficiency
N/A
Valuation / Funding
Funding History & Valuation Timeline
Complete history of all funding rounds and valuation milestones
| Date | Round | Amount | Post-Valuation | Growth |
|---|---|---|---|---|
| September 22, 2025 | Later Stage VC (Series D) | $125.0M | N/A | - |
| September 5, 2023 | Later Stage VC (Series C) | $90.0M | N/A | - |
| February 16, 2022 | Early Stage VC (Series A) | $100.0M | N/A | - |
Valuation Analysis
Current Valuation Metrics
Star Therapeutics is currently valued at N/A as of September 22, 2025. The company has raised a total of $315.0M in funding across 3 funding rounds.
What is Star Therapeutics Worth in 2026?
Star Therapeutics is a leading private company in the Biotechnology sector. Track Star Therapeutics's valuation history, funding timeline, and implied market value from secondary transactions on Premier Alternatives.
How Star Therapeutics Valuation is Determined
Private company valuations like Star Therapeutics's are determined through primary funding rounds led by venture capital firms, private equity investors, and strategic partners. The valuation reflects factors including revenue growth, market opportunity, competitive positioning, and investor sentiment.